Skip to main navigation
Pharvaris N.V logo
Main Menu

Header Nav

  • Home
  • About
  • Pipeline
  • Therapeutic Focus
  • Patients
  • Investors
  • Contact
  • Career
  • Search
Investor Menu

IR Nav

  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
    • Publications
  • Financials
    • SEC Filings
  • Stock
    • Stock Performance
    • Analyst Coverage
  • Corporate Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Committee Composition
  • Resources
    • FAQ
    • Contact Us
    • Email Alerts

Publications

Breadcrumb

Home / Investor Relations / NEWS & EVENTS / NEWS & EVENTS >> Publications
Pharmacological profile of PHA121 published in International Pharmacology
Mar 22, 2022
Publication
Bradykinin Challenge Provides Surrogate Endpoints For Hereditary Angioedema Treatment
Nov 13, 2020
Poster 664.1 KB
Presentation
PHA-022121, a Selective Bradykinin-B2-Receptor Antagonist, Is Safe and Shows Rapid Oral Bioavailability in Humans
Nov 13, 2020
Poster 746.5 KB
Presentation
In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist
Jul 30, 2020
Publication 1.7 MB
PHA-022121, a First in Class Oral Bradykinin B2 Receptor Antagonist in Clinical Development: Proof of Concept Study in a Translational Monkey Bradykinin Challenge Model
Apr 09, 2020
Poster 931.5 KB

Toolkit

Print Page
Print Page
Email Alerts
Email Alerts
IR Contacts
IR Contacts

Footer Links

Privacy     Cookie notice     Terms of Use

Social Links

  • Pharvaris 2020 - © All rights reserved